Current status of isolated limb infusion with mild hyperthermia for melanoma

International Journal of Hyperthermia

Volumn 24, Issue 3, 2008, Pages 219-225

  Thompson, John F ^a,c   Kam, Peter C A ^b,c  

^a MELANOMA INSTITUTE AUSTRALIA   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Isolated limb infusion; Melanoma; Regional chemotherapy

Indexed keywords

ACETYLSALICYLIC ACID; BUTHIONINE SULFOXIMINE; DACARBAZINE; DACTINOMYCIN; DEXAMETHASONE; FOTEMUSTINE; GLUTATHIONE; HEPARIN; MELPHALAN; PAPAVERINE; TEMOZOLOMIDE; TROPISETRON;

ANGIOGRAPHY; ARTERY CATHETERIZATION; ARTICLE; CANCER REGRESSION; CATHETER REMOVAL; CHROMOMYCOSIS; COMORBIDITY; COMPRESSION THERAPY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENTIATION; ELDERLY CARE; EXTRACORPOREAL CIRCULATION; HUMAN; HYPERTHERMIC THERAPY; LIMB BLOOD VESSEL; LIMB DISEASE; LIMB PERFUSION; LIMB SALVAGE; MEAN RESIDENCE TIME; MELANOMA; NAUSEA; OVERALL SURVIVAL; PATIENT MONITORING; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE NAUSEA; POSTOPERATIVE THROMBOSIS; PROGNOSIS; PROTECTIVE CLOTHING; RECURRENT CANCER; SIDE EFFECT; SKIN DISEASE; SKIN LYMPHOMA; SOFT TISSUE SARCOMA; TOURNIQUET; TREATMENT OUTCOME; VASCULAR SURGERY; VEIN CATHETERIZATION; VERRUCA VULGARIS;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; EXTREMITIES; HUMANS; HYPERTHERMIA, INDUCED; MELANOMA; SKIN NEOPLASMS;

EID: 42049107866     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730701827565     Document Type: Article

References (33)

1. Lens, MB and Dawes, M. (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol, 150, pp. 179-185.
2. Lingam, MK, Byrne, DS, Aitchison, T., MacKie, RM and McKay, AJ (1996) A single centre's 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limb. Eur J Cancer, 32, pp. 1668-1673.
3. Rossi, CR, Foletto, M., Vecchiato, A., Alessio, S., Menin, N. and Lise, M. (1997) Management of cutaneous melanoma M0: State of the art and trends. Eur J Cancer, 33, pp. 2302-2312.
4. Coit, DG (1998) Recurrent regional metastases and their management. Cutaneous melanoma, pp. 301-309. Quality Medical Publishing, St Louis
5. McKay, A. and Byrne, DS (2004) Recurrent limb melanoma: Treatments other than isolated limb perfusion and infusion. Textbook of melanoma, pp. 410-428. Martin Dunitz, London
6. Creech Jr., O., Krementz, ET, Ryan, RF and Winblad, JN (1958) Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit. Ann Surg, 148, pp. 616-632.
7. Thompson, JF and de Wilt, JH (2001) Isolated limb perfusion in the management of patients with recurrent limb melanoma: An important but limited role. Ann Surg Oncol, 8, pp. 564-565.
8. Thompson, JF, Waugh, RC, Saw, RPM and Kam, PCA (1994) Isolated limb infusion with melphalan for recurrent limb melanoma: A simple alternative to isolated limb perfusion. Reg Cancer Treat, 7, pp. 188-192.
9. Thompson, JF, Kam, PCA, de Wilt, JHW and Lindner, P. (2004) Isolated limb infusion for melanoma. Textbook of melanoma, pp. 429-437. Martin Dunitz, London
10. Mian, R., Henderson, MA, Speakman, D., Finkelde, D., Ainslie, J. and McKenzie, A. (2001) Isolated limb infusion for melanoma: A simple alternative to isolated limb perfusion. Can J Surg, 44, pp. 189-192.
11. Brady, MS, Brown, K., Patel, A., Fisher, C. and Marx, W. (2006) A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity. Ann Surg Oncol, 13, pp. 1123-1129.
12. Wieberdink, J., Benckhuysen, C., Braat, RP, van Slooten, EA and Olthuis, GA (1982) Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol, 18, pp. 905-910.
13. Thompson, JF, Lai, DT, Ingvar, C. and Kam, PC (1994) Maximizing efficacy and minimizing toxicity in isolated limb perfusion for melanoma. Melanoma Res, 4, pp. 45-50.
14. Vrouenraets, BC, Nieweg, OE and Kroon, BB (1996) Thirty-five years of isolated limb perfusion for melanoma: Indications and results. Br J Surg, 83, pp. 1319-1328.
15. Cavaliere, R., Ciocatto, EC, Giovanella, BC, Heidelberger, C., Johnson, RO, Margottini, M., Mondovi, B., Moricca, G. and Rossi-Fanelli, A. (1967) Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer, 20, pp. 1351-1381.
16. Siemann, DW, Chapman, M. and Beikirch, A. (1991) Effects of oxygenation and pH on tumor cell response to alkylating chemotherapy. Int J Radiat Oncol Biol Phys, 20, pp. 287-289.
17. Skarsgard, LD, Skwarchuk, MW, Vinczan, A., Kristl, J. and Chaplin, DJ (1995) The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake. Anticancer Res, 15, pp. 219-223.
18. Thompson, JF, Ramzan, I., Kam, PCA and Yau, DF (1996) Pharmacokinetics of melphalan during isolated limb infusion for melanoma. Reg Cancer Treat, 9, pp. 13-16.
19. Parsons, PG, Carter, FB, Morrison, L. and Mary, S Regius (1981) Mechanism of melphalan resistance developed in vitro in human melanoma cells. Cancer Res, 41, pp. 1525-1534.
20. Thompson, JF, Kam, PC, Waugh, RC and Harman, CR (1998) Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusion. Semin Surg Oncol, 14, pp. 238-247.
21. Lindner, P., Doubrovsky, A., Kam, PC and Thompson, JF (2002) Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma. Ann Surg Oncol, 9, pp. 127-136.
22. Sanki, A., Kam, PC and Thompson, JF (2007) Long-term results of hyperthermic, isolated limb perfusion for melanoma: A reflection of tumor biology. Ann Surg, 245, pp. 591-596.
23. Bonenkamp, JJ, Thompson, JF, de Wilt, JH, Doubrovsky, A., Lima, R de Faria and Kam, PC (2004) Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence. Eur J Surg Oncol, 30, pp. 1107-1112.
24. Ueno, T., Ko, SH, Grubbs, E., Pruitt, SK, Friedman, HS and Tyler, DS (2004) Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma. Am J Surg, 188, pp. 532-537.
25. Grubbs, EG, Ueno, T., Abdel-Wahab, O., Cheng, TY, Pruitt, SK, Colvin, O Michael, Freidman, HS and Tyler, DS (2004) Modulation of resistance to regional chemotherapy in the extremity melanoma model. Surgery, 136, pp. 210-218.
26. Hannay, J., Davis, JJ, Yu, D., Liu, J., Fang, B., Pollock, RE and Lev, D. (2007) Isolated limb perfusion: A novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma. Gene Ther, 14:8, pp. 671-681.
27. Naik, AM, Chalikonda, S., McCart, JA, Xu, H., Guo, ZS, Langham, G., Gardner, D., Mocellin, S., Lokshin, AE and Moss, B. (2006) Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates. Hum Gene Ther, 17, pp. 31-45.
28. Damian, DL, Barnetson, RS, Rose, BR, Bonenkamp, JJ and Thompson, JF (2001) Treatment of refractory hand warts by isolated limb infusion with melphalan and actinomycin D. Australas J Dermatol, 42, pp. 106-109.
29. Damian, DL, Barnetson, RS and Thompson, JF (2006) Treatment of refractory chromomycosis by isolated limb infusion with melphalan and actinomycin D. J Cutan Med Surg, 10, pp. 48-51.
30. Elhassadi, E., Egan, E., O'Sullivan, G. and Mohamed, R. (2006) Isolated limb infusion with cytotoxic agent for treatment of localized refractory cutaneous T-cell lymphoma. Clin Lab Haematol, 28, pp. 279-281.
31. van Ginkel, RJ, Thijssens, KM, Pras, E., van der Graaf, WT, Suurmeijer, AJ and Hoekstra, HJ (2007) Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: Three time periods at risk for amputation. Ann Surg Oncol, 14, pp. 1499-1506.
32. Thompson, JF, Kam, PCA, Waugh, RC and Harman, CR (1998) Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusion. Semin Surg Oncol, 14, pp. 238-247.
33. Lindner, P., Thompson, JF, De Wilt, JH, Colman, M. and Kam, PC (2004) Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma. Eur J Surg Oncol, 30, pp. 433-439.